文献速递系统性红斑狼疮

SLE患者临床特征、疾病活动度及健康相关生活质量与重性抑郁障碍的关联

Association of clinical characteristics, disease activity and health-related quality of life in SLE patients with major depressive disorder.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

结果显示36%患者存在MDD,其皮肤黏膜、血管、眼、肺及肌肉骨骼受累更多,疼痛VAS及整体评估评分更高,自评健康差与MDD显著相关,且所有LupusQoL域评分均显著降低。

要点

  • SLE患者中MDD患病率较高(36%),应常规筛查抑郁。
  • 疼痛VAS高、整体评估评分高及自评健康差与MDD相关。
  • MDD患者所有LupusQoL域评分均显著降低。

核心结论

  • SLE患者MDD的预测因素包括疼痛和整体评估评分较高、自评健康差或一般以及特定器官受累。
  • 这些发现有助于临床医生及时识别和管理MDD。

研究设计与样本

  • 用PHQ-9评估抑郁,≥10分判定为MDD,比较MDD组(n=32,36%)与非MDD组的 demographic、LupusQoL域及临床特征。
  • 采用χ2检验分类变量、Wilcoxon秩和检验非正态连续变量,并用log-binomial模型估计相对风险及95%置信限。

主要发现

  • MDD组较非MDD组更常见皮肤黏膜、血管、眼、肺及肌肉骨骼受累。
  • 自评健康为差/一般与MDD显著相关(P < 0.001,相对风险 = 0.48)。
  • 较高的疼痛视觉模拟评分以及患者和医生整体评估评分也与MDD相关。
  • MDD患者所有LupusQoL域评分均显著降低。

关键数值与推荐

  • PHQ-9评分≥10分判定为MDD。
  • 自评健康差/一般与MDD关联:P < 0.001,相对风险 = 0.48。

临床怎么用

  • 对SLE患者应关注疼痛、整体评估及自评健康,并筛查MDD。
  • 特定器官受累(皮肤黏膜、血管、眼、肺、肌肉骨骼)患者需警惕MDD。
  • MDD与LupusQoL全面下降相关,管理抑郁可能改善生活质量。

局限性

  • 横断面设计无法推断因果关系。
  • 未报告多变量调整后的独立风险因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the contributing factors associated with major depressive disorder (MDD) in SLE patients and examine the association between disease-specific health-related quality of life [lupus quality of life (LupusQoL)] domains and MDD. METHODS: Depression was assessed by the patient health questionnaire (PHQ)-9, and scores ≥10 indicate MDD. Demographic data, LupusQoL domains, clinical and other features of the SLE patients were described and compared between MDD (PHQ-9 ≥10) and non-MDD (PHQ-9 <10) groups using χ2 tests for categorical variables and Wilcoxon rank sum tests for non-normal continuous variables. The risk of MDD was evaluated for the patient and physician-reported features individually using log-binomial models to estimate relative risks and 95% confidence limits. RESULTS: Eighty-eight patients with SLE met eligibility criteria, with a mean (range) age of 48.6 (19-80), mostly female (80%) and with a mean disease duration of 13.2 years. Compared with the non-MDD group, patients with MDD (n = 32, 36%) were more likely to have the following SLE manifestations: mucocutaneous, vascular, ocular, pulmonary and musculoskeletal involvement. Self-rated health described as poor/fair was markedly associated with MDD (P < 0.001, relative risk = 0.48). Based on relative risks, higher pain visual analogue score, and patient and physician global assessment scores were also linked to MDD. The LupusQoL domain scores were notably lower in the MDD patients, with a statistically significant reduction in all LupusQoL domains. CONCLUSION: Predictors of MDD in SLE patients include higher scores in pain and global assessment, poor or fair self-reported health, and specific organ involvement. These findings may help clinicians to recognize and manage MDD promptly.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Parperis K, Psarelis S, Chatzittofis A, et al. Association of clinical characteristics, disease activity and health-related quality of life in SLE patients with major depressive disorder. Rheumatology (Oxford). 2021. PMID: 33547787. doi:10.1093/rheumatology/keab123

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。